Faculty statement from the CEU on a new publication: WHO Selected Practice Recommendations for Contraceptive Use update: Missed pills: New recommendations

Journal of Family Planning and Reproductive Health Care

Volumn 31, Issue 2, 2005, Pages 153-155

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABSTINENCE; CONDOM; CONTRACEPTION; DRUG DOSE REGIMEN; EVIDENCE BASED MEDICINE; INTERNET; ORAL CONTRACEPTION; PATIENT EDUCATION; PATIENT INFORMATION; PRACTICE GUIDELINE; PUBLICATION; REVIEW; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GREAT BRITAIN; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; PUBLICATIONS; WORLD HEALTH ORGANIZATION;

EID: 18044373904     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/1471189053629572     Document Type: Review

References (36)

1. World Health Organization (WHO). Selected Practice Recommendations for Contraceptive Use. Geneva, Switzerland: WHO, 2002.
2. Glasier A, Brechin S, Raine R, Penney G. A consensus process to adapt the World Health Organization Selected Practice Recommendations for UK use. Contraception 2003; 68: 327-333.
3. Faculty of Family Planning and Reproductive Health Care (FFPRHC). UK Selected Practice Recommendations for Contraceptive Use. London, UK: FFPRHC, 2002. http://www.ffprhc.org.uk.
4. World Health Organization (WHO). Selected Practice Recommendations for Contraceptive Use [Update]. Geneva, Switzerland: WHO, 2004. http://www.who.int/ reproductive-health/publications/spr_2/index.html.
5. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al for the Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20(Suppl. 3): 21-35.
6. Killiek SR, Eyong E, Elstein M. Ovarian follicular development in oral contraceptive cycle. Fertil Steril 1987; 48: 409-413.
7. Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Contraception 1986; 34: 513-522.
8. Killick SR, Bancroft K, Oelbaum S, Morris J, Elstein M. Extending the duration of the pill-free interval during combined oral contraception. Adv Contracept 1990; 6: 33-40.
9. Killick SR. Ovarian follicles during oral contraceptive cycles: their potential for ovulation. Fertil Steril 1989; 52: 580-582.
10. Rosenberg MJ, Waugh MS. Causes and consequences of oral contraceptive non-compliance. Am J Obstet Gynecol 1999; 180: 276-279.
11. Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med 1995; 40: 355-360.
12. Potter L, Oakley D, de Leon-Wong E, Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect 1996; 28: 154-158.
13. Aubeny E, Buhler M, Colau JC, Vicaut E, Zadikian M, Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur J Contracept Reprod Health Care 2002; 7: 155-161. combination oral contraceptive pills. Contraception 1980; 22: 241-247.
14. Aubeny E, Buhler M, Colau JC, Vicaut E, Zadikian M, Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur J Contracept Reprod Health Care 2002; 7: 155-161. combination oral contraceptive pills. Contraception 1980; 22: 241-247.
15. Creinin MD, Lippman JS, Eder SE, Godwin AJ, Olson W. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinylestradiol versus monophasic levonorgestrel/20 micro g ethinylestradiol. Contraception 2002; 66: 147-152.
16. Elomaa K, Lahteenmaki P. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. Contraception 1999; 60: 275-279.
17. Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, et al. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. Am J Obstet Gynecol 1998; 179: 41-46.
18. Hamilton CJ, Hoogland HJ. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. Am J Obstet Gynecol 1989; 161: 1159-1162.
19. Hedon B, Cristol P, Plauchut A, Vallon AM, Desachampts F, Taillant ML, et al. Ovarian consequences of the transient interruption of combined oral contraceptives. Im J Fertil 1992; 37(Suppl. 3): 162-168.
20. Killick SR. Ovarian follicles during oral contraceptive cycles: their potential for ovulation. Fertil Steril 1989; 52: 580-582.
21. Killick SR, Bancroft K, Oelbaum S, Morris J, Elstein M. Extending the duration of the pill-free interval during combined oral contraception. Adv Contracept 1990; 6: 33-40.
22. Landgren BM, Csemiczky G. The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive. Contraception 1991; 43: 149-159.
23. Landgren BM, Diczfalusy E. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. Contraception 1984; 29: 437-446.
24. Letterie GS. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. Contraception 1998; 57: 39-44.
25. Letterie GS, Chow GE. Effect of "missed" pills on oral contraceptive effectiveness. Obstet Gynecol 1992; 79: 979-982.
26. Molloy BG, Coulson KA, Lee JM, Watters JK. "Missed pill" conception: fact or fiction? BMJ (Clin Res Edn) 1985; 290: 1474-1475.
27. Morris SE, Groom GV, Cameron ED, Buckingham MS, Everitt JM, Elstein M. Studies on low-dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission. Contraception 1979; 20: 61-69.
28. Nuttall ID, Elstein M, McCafferty E, Seth J, Cameron ED. The effect of ethinyl estradiol 20 meg and levonorgestrel 250 meg on the pituitary-ovarian function during normal tablet-taking and when tablets are missed. Contraception 1982; 26: 121-135.
29. Spona J, Elstein M, Feichtinger W, Sullivan H, Ludicke F, Muller U, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996; 54: 71-77.
30. Sullivan H, Furniss H, Spona J, Elstein M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril 1999; 72: 115-120.
31. Tayob Y, Robinson G, Adams J, Nye M, Whitelaw N, Shaw RW, et al. Ultrasound appearance of the ovaries during the pill-free interval. Br J Fam Plann 1990; 16: 94-96.
32. van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception 1990; 42: 597-609.
33. van Heusden AM, Fauser BC. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 1999; 59: 237-243.
34. Wang E, Shi S, Cekan SZ, Landgren BM, Diczfalusy E. Hormonal consequences of "missing the pill". Contraception 1982; 26: 545-566.
35. Wilcox AJ, Dunson D, Baird DD. The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. BMJ 2000; 321: 1259-1262.
36. Wilcox AJ, Dunson DB, Weinberg CR, Trussell J, Baird DD. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception 2001; 63: 211-215.